Rallybio Corporaton (RLYB)

$0.52 +0.02 (4.97%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	20.75M
Revenue (ttm)	640,000.00
Net Income (ttm)	-57.78M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-9,028.13%
Debt to Equity Ratio	0.00

Volume	258,714
Avg Vol	3,496,330
Day's Range	N/A - N/A
Shares Out	41.61M
Stochastic %K	73%
Beta	-1.17
Analysts	Sell
Price Target	$1.00

Company Profile

Rallybio Corporation, a clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody which is in Phase II clinical trial for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT); and RLYB211 for the prevention of FNAIT. The company is also developing RLYB114, a pegylated complement factor 5 (C5)-tar...

Industry: Biotechnology

Sector: Healthcare

Phone: 203 859 3820

Website: www.rallybio.com

Address:

234 Church Street, Suite 1020, New Haven, United States

Dardpro Jul. 28 at 2:32 PM

$RLYB we meet again .50+ 🙄🤪

0 · Reply

TuJaro Jul. 25 at 11:55 AM

$RLYB wow 800K shares premarket will this thing fly today!?

2 · Reply

TAMR Jul. 25 at 9:20 AM

$RLYB morning folks, what's on the cards today?

0 · Reply

Marketmoverjoe Jul. 24 at 10:26 AM

$RLYB keep the green days rolling. 8% yesterday. 15% today. we'll take it

1 · Reply

Dardpro Jul. 23 at 2:17 PM

$RLYB this board has always been dry as fck tbh, been here awhile.

2 · Reply

Marketmoverjoe Jul. 22 at 7:35 PM

$RLYB where is the chatter

0 · Reply

Marketmoverjoe Jul. 22 at 10:40 AM

$RLYB quietly moving on up like the Jefferson's. Lets GO!

2 · Reply

RFKJR Jul. 21 at 7:54 PM

$AIRE $CLOV $RLYB $URG $HCTI

1 · Reply

rp7991 Jul. 21 at 7:44 PM

$RLYB Rallybio Corporation announced a definitive agreement to sell its interest in REV102 to its joint venture partner, Recursion Pharmaceuticals. The deal is valued at up to $25 million, with an upfront equity payment of $7.5 million and near-term milestone payments https://finance.yahoo.com/news/recursion-pharmaceuticals-acquires-full-rights-041438368.html

0 · Reply

rp7991 Jul. 21 at 7:37 PM

$RLYB any updates here?

0 · Reply